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Background: Nothing is known about the mechanisms by which increased ceramide in 29 
the lung contributes to allergic responses and asthma severity. 30 
Objective: We sought to investigate the functional role of ceramide in mouse models of 31 
allergic airway disease that recapitulate the cardinal clinical features of human allergic 32 
asthma. 33 
Methods: Allergic airway disease was induced in mice by repeated intranasal 34 
administration of house dust mite or the fungal allergen Alternaria alternata. Processes 35 
that can be regulated by ceramide and are important for severity of allergic asthma were 36 
correlated with ceramide levels measured by mass spectrometry.  37 
Results: Both allergens induced massive pulmonary apoptosis and also significantly 38 
increased reactive oxygen species in the lung. Prevention of increases in lung ceramide 39 
levels mitigated allergen-induced apoptosis, reactive oxygen species, and neutrophil 40 
infiltration. In contrast, dietary supplementation of the anti-oxidant α-tocopherol 41 
decreased reactive oxygen species but had no significant effects on ceramide elevation 42 
or apoptosis, indicating that the increases in lung ceramide levels in allergen-challenged 43 
mice are not mediated by oxidative stress. Moreover, specific ceramide species were 44 
altered in bronchoalveolar lavage fluid from patients with severe asthma compared to 45 
non-asthmatics. 46 
Conclusion: Our data suggest that ceramide elevation after allergen challenge 47 
contributes to apoptosis, reactive oxygen species generation, and neutrophilic infiltrate 48 
that characterize the severe asthmatic phenotype. Ceramide might be the trigger of 49 
formation of Creola bodies found in the sputum of patients with severe asthma and 50 
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could be a biomarker to optimize diagnosis and to monitor and improve clinical 51 




Capsule Summary 56 
The bioactive sphingolipid metabolite ceramide is increased in lungs of allergen-57 
challenged mice and severe asthmatic patients, promotes apoptosis, oxidative stress 58 
and neutrophil recruitment that contribute to allergic asthma and correlates with asthma 59 
severity. 60 
Clinical Implications statement  61 
Our work suggests that allergen-induced ceramide elevation is the initial trigger of the 62 
apoptotic process leading to Creola body formation. Ceramide in bronchoalveolar 63 
lavage fluid has the potential to serve as a biomarker for specific asthma endotypes and 64 
disease severity. 65 
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Abbreviations used: AHR, airway hyperresponsiveness; Alt, Alternaria alternata; 68 
BALF, bronchoalveolar lavage fluid; CerS, ceramide synthase; GWAS, genome-wide 69 
association studies; FB1, fumonisin B1; HDM, house dust mite; LC-ESI-MS/MS, liquid 70 
chromatography–electrospray ionization–tandem mass spectrometry; Myr, myriocin; 71 
ORMDL3, ORM1 (yeast)-like protein 3; ROS, reactive oxygen species; SARP, Severe 72 
Asthma Research Program; SPT, serine palmitoyltransferase; S1P, sphingosine-1-73 
phosphate; TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick end-74 
labeling. 75 
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More than 25 million Americans suffer from asthma, a chronic airway disease 78 
marked by airflow obstruction, airway hyperreactivity, and pulmonary inflammation. The 79 
heterogeneous nature of asthma complicates treatment options and hampers the 80 
development of a cure. However, over the years, extensive research has advanced 81 
understanding of the initiation and progression of this disease. There is a strong genetic 82 
component to asthma and numerous genome-wide association studies (GWAS) have 83 
identified ORM (yeast)-like protein isoform 3 (ORMDL3) as a gene associated with the 84 
onset of allergic asthma, the most common type 1-6. ORMDL3 is one of 3 members of 85 
the mammalian ORMDL family proteins, which are endogenous negative regulators of 86 
serine palmitoyl transferase (SPT), the rate-limiting enzyme of the de novo sphingolipid 87 
biosynthesis pathway 7. This evolutionarily conserved function of ORMDL3 as a 88 
regulator of sphingolipid synthesis instigated interest into how sphingolipids may be 89 
involved in the pathology of asthma. Intriguingly, we found that although physiologically, 90 
ORMDL3 is a negative regulator of ceramide de novo biosynthesis, highly elevated 91 
pathological ORMDL3 expression, such as observed in allergic asthma, enhanced 92 
ceramide levels primarily due to increased sphingolipid degradation in the salvage 93 
pathway 8. Ceramide, the central metabolite of the sphingolipid pathway 9, is increased 94 
in lungs of guinea pigs by aerosol administration of ovalbumin 10 and in lungs of house 95 
dust mite (HDM) challenged mice 8. Moreover, inhibition of ceramide production in the 96 
lung protected HDM challenged mice from inflammation and airway hyperreactivity 8. In 97 
addition, intratracheal delivery of ceramide caused lung inflammation, tissue 98 
remodeling, and airway flow obstruction 11. Because ceramide is a bioactive signaling 99 
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molecule involved in the regulation of several biological processes that may contribute 100 
to asthma 12, 13, these results led us to investigate the functional role of ceramide in 101 
mouse models of allergic airway disease that recapitulate the cardinal clinical features 102 
of human allergic asthma. Our data suggest that ceramide elevation after allergen 103 
challenge plays a key role in airway epithelial cell apoptosis, oxidative stress, and 104 
neutrophil infiltration, processes that amplify and contribute to asthma severity in mice 105 
and humans 14, 15. Moreover, specific ceramide species were altered in bronchoalveolar 106 
lavage fluid (BALF) from severely asthmatic patients compared to non-asthmatics and 107 
correlated with airway neutrophilia, suggesting that ceramide has the potential to serve 108 
as a biomarker for specific asthma endotypes and disease severity.  109 
METHODS  110 
Mouse models of allergic asthma 111 
 Female C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, 112 
ME) and housed in the animal care facilities at Virginia Commonwealth University under 113 
standard temperature, humidity, and timed light conditions and provided with standard 114 
rodent chow and water ad libitum. All animal protocols and procedures were approved 115 
by the Institutional Animal Care and Use Committee at Virginia Commonwealth 116 
University. In an acute HDM-dependent asthma model, eight-week-old mice 117 
were challenged intranasally (i.n.) with house dust mite (15 µg HDM/25 µL saline) from 118 
Greer Laboratories (Lenoir, NC; XPB70D3A2.5) or saline on days 1 - 5 and days 8 - 12, 119 
for a total of 10 challenges. To inhibit ceramide biosynthesis, thirty minutes before HDM 120 
challenge, mice were injected intraperitoneally (i.p,) with vehicle, myriocin (0.3 mg/kg), 121 
or FB1 (0.5 mg/kg) on days 10, 11, and 12. This route of administration was selected as 122 
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instilling these inhibitors directly to the lung induced massive damage and i.p. treatment 123 
with fumonisin B1 (FB1) and myriocin at these concentrations did not affect circulating 124 
lymphocytes 16.  125 
 In a HDM model of allergic asthma with a strong antigen-specific IgE response, 126 
female mice (8 weeks old) were immunized by an i.p. injection of HDM (50 µg in 100 µl 127 
saline) together with 100 µl of Imject alum on day 1. On days 15, 18, and 21, mice were 128 
challenged i.n. with HDM (25 µg in 25 µl saline).  129 
 For the fungal allergen model, mice were challenged i.n. with Alternaria alternata 130 
(25 µg Alt/25 µl saline) from Greer Laboratories (XPM1D3A2.5) on days 1, 4, 7, and 10.  131 
Tocopherol diet 132 
 C57BL/6J mice were challenged intratracheally (i.t.) with HDM (10 µg/50 µl 133 
saline) or saline 3 times per week for a total of 6 or 8 challenges. During these 134 
challenges, mice were fed either an α-tocopherol-supplemented (250 mg/kg) diet or 135 
standard rodent chow diet. 24 h following the last challenge, lung tissue was collected 136 
17.  137 
Assessment of airway function 138 
 Mice were anesthetized with a mixture of ketamine (100 mg/kg), xylazine (10 139 
mg/kg), and acepromazine (2 mg/kg) i.p. followed by insertion of an 18-guage cannula 140 
into the trachea and placement onto the FlexiVent apparatus (Scireq, Montreal, 141 
Canada). Ventilation was started and mice were injected i.p with the paralytic 142 
decamethonium bromide (0.5 mg). Airway hyperresponsiveness was measured in 143 
response to increasing doses of nebulized methacholine (0-100 mg/ml) as described 8. 144 
  James   
 
8
Whole respiratory system resistance (R) was reported as calculated (cmH20/mL/sec) in 145 
the FlexiVent software version 8.0.4. 146 
Mass spectrometry measurements of sphingolipids 147 
 Lipids were extracted from lung tissue and sphingolipids were quantified by liquid 148 
chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), 149 
as previously described 8. 150 
Measurement of reactive oxygen species 151 
 Reactive oxygen species (ROS) were measured in snap-frozen lung tissue 152 
homogenized in PBS using a general oxidative stress indicator 14. Briefly, lung tissue 153 
homogenates were incubated with 0.04 mM CM-H2DCFDA (ThermoFisher) for 20 min 154 
at 37° C on a thermomixer (Eppendorf) and then centrifuged at 1400 rpm for 5 min at 4° 155 
C. Aliquots of the supernatants (50 µL) were placed in wells of a 96 well black bottom 156 
plate with clear bottoms (CELLSTAR). Fluorescence was measured with a TECAN 157 
infinite M1000 Pro plate reader at an excitation wavelength of 495 nm and emission 158 
wavelength of 527 nm and normalized to protein concentration measured with the BCA 159 
Protein Assay Kit (ThermoFisher).  160 
Clinical cohort and sample collection  161 
 Asthmatic and healthy subjects were previously recruited to the Severe Asthma 162 
Research Program (SARP1-2), an NHLBI-funded study designed to characterize 163 
molecular, cellular, and physiological phenotypes of severe and non-severe asthmatics 164 
18. Details regarding SARP1 were described previously 19. Subjects 13 years of age and 165 
older with asthma and healthy control subjects were recruited and American Thoracic 166 
Society guidelines were used to categorize subjects as severe (n = 10) or non-severe 167 
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asthma (n = 5) or healthy controls (n = 5) 20. Control subjects were nonsmokers with no 168 
history of lung disease. BAL was performed with five 50 mL aliquots of saline, and BALF 169 
was recovered by hand suction. An aliquot of cell-free BALF supernatant (1 mL) stored 170 
at -80°C was shipped to VCU for sphingolipid analyses. 171 
Statistical analyses 172 
 Statistical significances were determined with unpaired 2-tailed Student’s t test for 173 
comparison of 2 groups, or by ANOVA for multiple comparisons using GraphPad Prism 7.0 174 
software (San Diego, CA). For all experiments, the normality of each group was first 175 
checked with the Shapiro-Wilk statistical test. In case of non-normally distributed data, 176 
Mann Whitney or Kruskal-Wallis tests were done. Significance defined as *P < 0.05, **P 177 
< 0.01, and ***P < 0.001. Experiments were repeated three times with similar results. 178 
For clinical correlation analyses, Pearson’s product-moment correlation (r) and the 179 
strength of the relationship (p-value) for BALF sphingolipid species and lung function 180 
and cell infiltration measurements were calculated and generated a correlation matrix 181 
plotted using Prism 7. Highly significant correlations were accepted for r>0.7 and r< -0.7 182 
with P-values <0.05. For neutrophil populations, Spearman non-parametric correlations 183 
were determined.  184 
 BALF collection and analysis, isolation of primary lung alveolar epithelial cells, 185 
apoptosis determination with Annexin V and 7-AAD, measurement of ROS production 186 
by epithelial cells, neutrophil isolation and neutrophil attachment assays, 187 
immunocytochemistry and western blot analysis are detailed in the Methods section in 188 
this article’s Online Repository. 189 
RESULTS 190 
  James   
 
10
HDM challenge increases lung ceramide accompanied by increased apoptosis 191 
and ROS 192 
 To examine the role of ceramide in allergic asthma, mice were sensitized with ten 193 
intranasal injections of HDM over the duration of two weeks. This acute model 194 
stimulates airway inflammation and hypersensitivity and excessive mucus production 195 
commonly observed in asthmatic patients 21, 22. Consistent with previous studies 8, 23, 24, 196 
mice sensitized with HDM developed features of allergic asthma, including marked 197 
increase in BALF of eosinophils, as well as T and B cells and neutrophils to a lesser 198 
extent (Fig. 1A), and airway hyperresponsiveness (AHR) (Fig. 1B). Although a recent 199 
study suggested that HDM challenge did not affect ORMDL3 expression 25, in 200 
accordance with previous reports 8, 26, 27, we observed that HDM induced a robust 201 
increase in expression of ORMDL3 in lungs (Fig. 1C). As we 8 and others 25 reported 202 
previously, there was a significant increase in levels of multiple ceramide species with 203 
varying acyl chain lengths, particularly the predominant lung species C16:0, C24:0 and 204 
C24:1 in lungs of HDM challenged mice (Fig. 1D). However, levels of the major 205 
phosphatidylcholine 34:2 species were unaltered (Fig. 1E), suggesting that there was a 206 
specific increase in the bioactive sphingolipid metabolite ceramide.  207 
 To begin assessing the role of ceramide, we examined processes in which 208 
ceramide is known to play key roles, including apoptosis and generation of ROS 9, 28 209 
that could contribute to allergic asthma 12, 13. Exposure to allergens induces extensive 210 
damage and apoptosis of airway epithelium that are related to both chronicity and 211 
severity of asthma 29-31. Indeed, Creola bodies, which are clusters of apoptotic lung 212 
epithelial cells, have long been described in the sputum of asthmatic patients 29, 32. Yet 213 
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little is known of the initial trigger of the apoptotic process. In agreement with others 14, 214 
33, we found that HDM challenge induced activation of caspase 3, the final executionary 215 
step preceding apoptosis, as measured by increased levels of cleaved caspase 3 in 216 
immunoblots (Fig. 1C). Increased apoptosis in the lungs of HDM challenged mice was 217 
also confirmed by immunohistochemical staining with antibody against cleaved caspase 218 
3 (Fig. E1). Since elevated ceramides can increase ROS leading to apoptosis 9, 34, and 219 
it was shown that ROS and oxidative stress contribute to asthma pathology in mice and 220 
humans 14, 15, we next measured ROS production. HDM exposure increased lung ROS 221 
measured fluorometrically with CM-H2DCFDA (Fig. 1F). 222 
 Consistent with elevation of lung ceramide determined by mass spectrometry 223 
(Fig. 1D), lung sections from HDM-challenged mice but not saline treated mice also 224 
displayed increased staining with a specific anti-ceramide antibody 35 (Fig. 2A and Fig. 225 
E2). Lung cells with increased ceramide staining also showed increased co-staining for 226 
activated/cleaved caspase 3 (Fig. 2A), suggesting that ceramide may contribute to the 227 
increased apoptosis. Ceramide staining only partially co-localized with airway smooth 228 
muscle cells (Fig. E3). Importantly, increased ceramide and cleaved caspase-3 staining 229 
predominantly co-localized with cytokeratin 18, a marker for epithelial cells (Fig. 2B and 230 
Fig. E4), which are the first line of defense against inhaled allergens and are now 231 
recognized as important players in asthma pathogenesis 36.  232 
Lung ceramide, apoptosis, and ROS are increased in several mouse models of 233 
allergic asthma 234 
 We next expanded our studies to examine effects of ceramide elevation, 235 
apoptosis, and ROS in other murine models of experimental asthma. In a model that 236 
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induces a strong antigen-specific IgE response and mast cell hyperplasia with moderate 237 
eosinophilia 37, 38, mice were sensitized i.p. with HDM in alum as an adjuvant and then 238 
challenged intranasally three times with HDM alone. Sensitization and challenges with 239 
HDM/alum induced AHR (Fig. 3A) with a significant increase in IgE and activation of 240 
mast cells (Fig. 3B and data not shown). In parallel, there was an increase in 241 
neutrophils and eosinophils in BALF (Fig. 3C). ORMDL3 expression was also increased 242 
(Fig. 3D), as well as many ceramide species (Fig. 3E). Concomitantly, caspase 3 243 
activation (Fig. 3D) and generation of ROS (Fig. 3F) were also significantly increased. 244 
 To exclude HDM-dependent effects and to examine responses to other potent 245 
allergens, mice were exposed to the fungal extract of Alternaria alternata, another 246 
common allergen associated with allergic asthma disease 39. As was reported 247 
previously 25, 27, 40, Alternaria induced the hallmark features of asthma in mice, including 248 
AHR, lung and airway inflammation, eosinophilia (Fig 3G,H), as well as increased 249 
ORMDL3 (Fig. 3I). In addition to increased ORMDL3, there was also significantly 250 
increased ceramide levels, particularly C16;0, C24:0, and C24:1 species, in the lungs of 251 
sensitized mice (Fig. 3J). Concurrently, caspase 3 cleavage (Fig 3I) and ROS were also 252 
increased compared to saline treated mice (Fig. 3K). Taken together, these results 253 
demonstrate that challenge with diverse allergens increases ceramide levels that 254 
correlate with induction of apoptosis and increased levels of ROS in the lung.  255 
Allergen induced ceramide and apoptosis is independent of ROS production 256 
 The links between ceramide, ROS, and apoptosis are complex. On the one hand, 257 
increased ROS in the lung can lead to increased ceramide production and apoptosis 41, 258 
42. On the other hand, increased ceramide can lead to ROS production and apoptosis 34, 259 
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42, 43. Therefore, it was of interest to complete the elucidation of the sequence of events 260 
prevalent during allergic asthma and determine the effects of suppressing ROS 261 
production on ceramide and apoptosis. To this end, HDM-challenged mice were fed a 262 
normal diet supplemented with the anti-oxidant α-tocopherol, a vitamin E isoform that 263 
has been shown to decrease ROS in vivo and lung inflammation in response to HDM 264 
challenge 17, 44. As expected, the α-tocopherol-supplemented diet significantly reduced 265 
lung ROS levels in HDM challenged mice compared to normal diet (Fig. 4A). In contrast, 266 
however, α-tocopherol supplementation did not decrease elevation of lung ceramide 267 
species induced by HDM challenge (Fig. 4B). Similarly, decreasing ROS production in 268 
these mice did not suppress apoptosis as measured by caspase 3 activation (Fig. 4C). 269 
These results suggest that allergen-induced increased ceramide and apoptosis are 270 
independent of its effects on ROS.  271 
Allergen-induced ROS and apoptosis is ceramide-dependent  272 
 We have previously shown that treatment of HDM-challenged mice with the SPT 273 
inhibitor myriocin or fumonisin B1 (FB1), an inhibitor of ceramide synthases (CerS) (Fig. 274 
5A), for the last 3 days of allergen challenge reduced lung ceramide levels and 275 
markedly suppressed AHR to methacholine 8. Therefore, we examined whether 276 
preventing ceramide elevation affects apoptosis or ROS production. Indeed, i.p. 277 
treatment with myriocin 30 min prior to HDM challenges on days 10, 11, and 12, 278 
prevented elevation of all ceramide species in BALF (Fig. 5B), more potently than 279 
treatment with FB1. This data suggests that ceramide elevation is due to increased 280 
biosynthesis and salvage/recycling to a lesser extent. In agreement, dihydroceramides, 281 
precursors of ceramides and intermediates in its de novo biosynthesis, are also 282 
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increased in lung 8 and in BALF from HDM challenged mice and are decreased by 283 
these inhibitors (Fig. 5B). Acidic sphingomyelinase, which cleaves sphingomyelin to 284 
ceramide, has been implicated in bronchial asthma in mice 45. However, in contrast to 285 
significant increases in ceramides and dihydroceramides, sphingomyelin levels were 286 
essentially unchanged after exposure to HDM (Fig. E5), indicating that sphingomyelin 287 
degradation is not a major contributor to ceramide elevation. Interestingly, treatment 288 
with these inhibitors not only mitigated the increase in ceramides, they markedly 289 
reduced lung epithelial cell apoptosis induced by HDM as demonstrated by reduced 290 
TUNEL staining (Fig. 5C) and reduced caspase 3 cleavage in western blots (Fig. 5D) 291 
and also completely prevented ROS formation in the lung (Fig. 5E). These results 292 
suggest that allergen-induced apoptosis and ROS production in the lung are due to 293 
elevated ceramide.  294 
 To elucidate the direct effect of HDM and increased ceramide on apoptosis and 295 
ROS formation, primary lung epithelial cells were treated with HDM or D-erythro-C6-296 
ceramide, which is converted in cells to endogenous C16- and C24-ceramide 46. Both 297 
HDM and C6-ceramide reduced viable cells with an increase in both early and late 298 
apoptotic cells (defined as Annexin V+) (Fig. E6A,B), as well as ROS generation, 299 
measured by fluorescence of intracellular oxidized DCF (Fig. E6C). FB1 inhibited 300 
apoptosis and ROS generation induced by HDM or C6-ceramide, whereas myriocin 301 
mitigated the effects of HDM but was less effective in C6-ceramide treated cells, 302 
consistent with the notion that generation of endogenous ceramides from short-chain 303 
ceramides requires deacylation and reacylation catalyzed by CerS 46. These results 304 
suggest that, even in the absence of immune cells, HDM on its own can trigger 305 
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bronchial epithelial cell apoptosis and ROS generation in a ceramide-dependent 306 
manner.  307 
Levels of specific ceramide species associate with asthma severity in patients 308 
 Next, it was of interest to determine whether ceramide levels were also increased 309 
in asthmatic patients. BALF is the most reliable specimen to examine the fluid lining of 310 
the lower respiratory tract and is often used for physiologically relevant asthma studies 311 
47. Therefore, sphingolipid profiles were determined in BALF from healthy controls and 312 
from asthmatic patients recruited from SARP1-2 19 and classified by clinical activity as 313 
having no, mild, or severe disease. Relative to non-severe asthmatics, individuals with 314 
severe asthma had higher SARP Severity type scores. Spirometric measures of lung 315 
function including FEV1% and FVC% were lower in severe asthmatics than in non-316 
severe asthmatics or healthy controls despite the usage of higher doses of inhaled 317 
corticosteroids and oral corticosteroids by severe asthmatics (Table I).  318 
 All ceramide species in BALF from severe asthmatics, except C18:1, were 319 
increased compared to healthy controls, with significant increases in C20, C26, and 320 
C26:1 ceramides (Fig. 6A). However, these increases in ceramide species were not 321 
observed in mild asthmatics. Somewhat unexpectedly, there were no significant 322 
differences in BALF levels of the bioactive sphingolipid metabolite sphingosine-1-323 
phosphate (S1P) or the sphingoid bases, sphingosine and dihydrosphingosine, among 324 
the three groups (Fig. 6A).  325 
 Next, we examined whether changes of these ceramide species in the BALF 326 
correlated with lung function or immune cells infiltration. Several strong correlations 327 
were revealed by unbiased correlation matrix analysis (Fig. 6B). All ceramides with 328 
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different acyl chain lengths correlated with each other. Remarkably, there were also 329 
positive correlations between ceramides, particularly C16:0, C26:1, and C26:0, with the 330 
degree of neutrophil infiltration (Fig. 6BC). Moreover, these species also correlated with 331 
airway obstruction determined by FEV1pp and FEV1/FVC (Fig. 6C). Taken together, 332 
these data suggest that specific ceramide species correlate with markers of asthma 333 
severity and airway neutrophilia, which has been associated with asthma exacerbations 334 
that are refractory to corticosteroid treatment 48.  335 
Involvement of ceramide in HDM-induced recruitment of neutrophils into the lung 336 
 We previously found that blocking ceramide elevation prevented AHR and 337 
decreased accumulation of eosinophils in HDM challenged mice 8. Whereas type 2 338 
eosinophilic inflammation is found in most asthmatics, a subset of patients has severe 339 
debilitating disease with neutrophil-predominant lung inflammation 48. Because we 340 
found association in asthmatic patients between ceramide, asthma severity, and airway 341 
neutrophilia (Fig. 6B,C), it was of interest to examine the involvement of ceramides in 342 
aeroallergen-induced neutrophil recruitment into the lung. Immunofluorescence staining 343 
of lung sections with neutrophil-specific anti-Ly6G 49 revealed intense staining after 344 
HDM exposure, which was greatly reduced by treatment with myriocin or FB1 (Fig. 7A). 345 
Likewise, staining for myeloperoxidase (MPO), found predominantly in neutrophil 346 
granules and a marker of their activation, was increased by HDM and suppressed by 347 
the inhibitors of ceramide formation (Fig. 7A). Furthermore, consistent with a previous 348 
report 50, increasing lung ceramide by intranasal instillation of C16:0 ceramide, 349 
significantly increased numbers of neutrophils (CD11b+CD11c-SiglecF-Ly6G+) in the 350 
BALF (Fig. 7B). 351 
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 To further examine whether increased ceramide in the epithelium triggers 352 
neutrophil recruitment, primary lung epithelial cells were treated for 20 h with HDM or D-353 
erythro-C6-ceramide in the absence or presence of FB1 or myriocin to increase or 354 
suppress ceramide elevation, respectively. Treatment of primary lung epithelial cells 355 
with HDM or C6-ceramide increased neutrophil adhesion to the epithelial monolayer, 356 
which was reduced by myriocin or FB1 (Fig. 7C,D). Taken together, this data support a 357 
role for ceramide elevation in allergen-initiated lung neutrophil recruitment. 358 
Discussion 359 
 Exposure to airborne allergens such as HDM and Alternaria alternata are major 360 
causes of allergic asthma. The airway epithelium is the first line of defense of the lung 361 
and plays a key role in allergic sensitization and remodeling 36, 51. These aeroallergens 362 
can also induce apoptosis and oxidative stress of the airway epithelium in mice, 363 
compromising its barrier function, increasing susceptibility to lung inflammation, leading 364 
to exacerbation of asthma 36. However, the underlying mechanisms that trigger these 365 
events have not been fully elucidated. Here we demonstrated that HDM and Alternaria 366 
induced significant increases in the pro-apoptotic sphingolipid metabolite ceramide in 367 
bronchial epithelium. Prevention of ceramide elevation mitigated HDM-induced lung 368 
apoptosis, oxidative stress, and neutrophilia indicative of the critical role of ceramide in 369 
activating these processes. Importantly, pronounced reduction of AHR, eosinophils 8 370 
and neutrophils in BALF, apoptosis, and oxidative stress was observed even when 371 
inhibitors of ceramide production were only administered during the late asthmatic 372 
responses. These observations provide direct evidence for the importance of ceramide 373 
in asthma-induced pathology.  374 
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 Clusters of apoptotic bronchial epithelial cells, known as Creola bodies, have 375 
long been noted in the sputum of severe asthmatics 32, 52. Creola bodies were detected 376 
in sputum of 60% of pediatric asthmatic patients, which correlated with mobilization into 377 
the airway of neutrophils but not eosinophils 29, 53. Consistent with data from 378 
aeroallergen challenged mice 14, 54, there are several reports of apoptotic epithelial cells 379 
in endobronchial biopsies of adult patients with chronic, persistent asthma but not in 380 
biopsies from healthy volunteers 29-31, 55. Based on our data, we speculate that ceramide 381 
elevation leading to caspase 3 activation, a crucial mediator of apoptosis, is the initial 382 
trigger of the apoptotic process leading to Creola body formation.  383 
 The recruitment and activation of neutrophils must be tightly regulated to balance 384 
their effector functions with their ability to damage tissues by release of proteases and 385 
ROS 56. Our finding that allergen-driven airway neutrophilia was decreased by blocking 386 
ceramide elevation is important as neutrophilic inflammation in the asthmatic lung is 387 
associated with impaired lung function and more severe disease 48, 56, 57. Ceramide 388 
treatment of neutrophils enhanced several pro-inflammatory pathways, including 389 
chemotaxis, phagocytosis, and neutrophil extracellular trap (NET) formation 58, a 390 
process by which neutrophils externalize web-like chromatin strands containing 391 
antimicrobial peptides, proteases, and cytotoxic enzymes 59. Recently it was shown that 392 
NET formation is induced in allergic lung after exposure to an aeroallergen 59. Thus, it is 393 
possible that elevation of ceramide we observed in the lung and BALF may also 394 
contribute to neutrophilic inflammation in severe asthma. 395 
 Allergic asthma is associated with increases in ROS that are critical for the 396 
initiation of inflammatory responses 60. ROS levels are elevated in the lavage fluid of 397 
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asthmatic patients, likely produced by NADPH oxidase in immune cells infiltrating the 398 
lungs or by airway epithelial cells 61. Markers of oxidative stress, including nitric oxide 399 
and 8-isoprostane, are elevated in exhaled breath condensate during asthma 400 
exacerbation and in patients with severe asthma 62. Consistent with previous studies 14, 401 
63, we observed that HDM and Alternaria challenges induced lung ROS generation. 402 
Moreover, inhibitors of ceramide generation also blocked ROS production in response 403 
to these aeroallergens. However, dietary supplementation of α-tocopherol, the isoform 404 
that contributes to the anti-oxidative and anti-inflammatory effects 17, 44, reduced HDM-405 
induced ROS as expected, but had no effect on increases of ceramide or apoptosis. 406 
These data indicate that although lung oxidative stress is involved in airway 407 
inflammation 64, it is not the cause for allergen-induced ceramide generation or 408 
apoptosis that leads to extensive lung damage. Moreover, the α-tocopherol 409 
supplemented diet reduced AHR and eosinophil but not neutrophil infiltration 44, 410 
suggesting that an ROS-independent mechanism drives neutrophil recruitment. These 411 
results may also explain some of the inconsistent outcomes from clinical reports on the 412 
associations of vitamin E and asthma and its potential beneficial effects 65, 66. 413 
 Asthma is a very heterogeneous disease with multiple phenotypes and different 414 
onset, course, and treatment responses and there is a great need for biomarkers to 415 
improve diagnosis and treatment 67, 68. Interestingly, our targeted sphingolipidomic 416 
analyses showed that specific ceramide acyl chain species, including C16, the 417 
predominant species, and particularly the very long chain C20, C26, and C26:1, were 418 
increased in BALF from severe asthmatic patients but not in mild asthmatics, whereas 419 
C18:1 was reduced in both mild and severe asthmatics. Somewhat surprisingly, S1P, 420 
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which has previously been implicated in allergic asthma 69, 70, was not significantly 421 
increased. These results support the physiological relevance of ceramide elevation in 422 
exacerbation of allergic asthma. An untargeted metabolomics analysis of serum from 423 
healthy individuals and asthmatics also found that increased levels of ceramide 424 
positively correlated with asthma severity 71. However, the physiological relevance to 425 
asthma of changes in sphingolipids in the circulation is unclear.  426 
 The strengths of this study are that it represents carefully phenotyped asthmatic 427 
patients, eliminated self-reporting bias, contains extensive information on lung function 428 
and disease severity, and corticosteroid treatment. Thus an unbiased correlation matrix 429 
analysis revealed that these ceramide species significantly correlated with lung function, 430 
and intriguingly, strongly correlated with neutrophil infiltration. Increased airway 431 
neutrophil infiltration has been associated with asthma severity and asthma 432 
exacerbations 48, 57. Neutrophilia also correlates with asthma that is refractory to 433 
corticosteroids, the mainstay of asthma treatment 48, 57. Here, we have identified 434 
significant associations between increased levels of specific ceramide species in BALF 435 
with neutrophilic lung inflammation, asthma severity, and resistance to corticosteroids. 436 
Hence, these ceramide species could potentially identify endotypes for corticosteroid 437 
resistant severe asthma and also be biomarkers to optimize diagnosis and to monitor 438 
and improve clinical outcomes in asthma. 439 
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FIGURE LEGENDS 673 
FIG 1. House dust mite challenge increases ceramide, apoptosis, and ROS in the 674 
lung. (A-D) C57Bl/6J mice were sensitized and challenged intranasally with HDM or 675 
saline and lungs examined on day 15. (A) Inflammatory cells in BALF. (B) Airway 676 
resistance in response to increasing doses of nebulized methacholine was measured 677 
with the FlexiVent system. (C) Proteins in lung lysates were separated by SDS-PAGE 678 
and immunoblotted with the indicated antibodies. Blots were stripped and re-probed 679 
with anti-tubulin to show equal loading and transfer. (D,E) Lipids were extracted and (D) 680 
ceramide species and (E) phosphatidylcholine (PC, 34:2) measured by LC-ESI-MS/MS. 681 
(F) ROS was determined with CM-H2DCFDA and fluorescence measured. Data are 682 
mean ± SEM. A: n=4 and 5 mice/group; B, C: n=3 and 3, D-F: n=4 and 4 for saline and 683 
HDM, respectively. *P < 0.05, ***P < 0.001, compared to each saline control. Similar 684 
data were obtained in 2 additional experiments. 685 
FIG 2. Increased ceramide staining in HDM-challenged mice co-localizes with 686 
cleaved caspase 3 in lung epithelium. (A) Mice were challenged i.n. with HDM or 687 
saline and lungs as indicated and examined on day 15 as described in Fig 1. Lung 688 
sections were stained with anti-ceramide antibody (red), anti-cleaved caspase 3 689 
antibody (green). Lower panels are zoom boxes indicated in middle panels. (B) Lung 690 
sections were stained with anti-ceramide antibody (red), anti-cleaved caspase 3 691 
antibody (green) and anti-cytokeratin 18 (yellow), a marker for epithelial cells. (A,B) All 692 
sections were co-stained with DAPI to visualize nuclei (blue). Co-localization is shown in 693 
the overlay panels. Size bar: 50 or 10 µm as indicated.  694 
FIG 3. Lung ceramide, apoptosis, and ROS are increased in different allergen-695 
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driven asthma models. (A-F) Mice were sensitized i.p. with HDM (50 µg HDM in alum), 696 
and then challenged i.n. on days 15, 18, and 21 with HDM (25 µg in saline) or saline 697 
alone as indicated, and lungs examined on day 24. (A) Airway resistance in response to 698 
increasing doses of nebulized methacholine was measured with the FlexiVent system. 699 
(B) Eosinophils and neutrophils in BALF. (C) Serum IgE levels. (D) Proteins in lung 700 
lysates were analyzed by immunoblotting with the indicated antibodies. Blots were 701 
stripped and re-probed with anti-tubulin to show equal loading and transfer. (E) Lipids 702 
were extracted and ceramide species were measured by LC-ESI-MS/MS. (F) ROS was 703 
measured fluorometrically. A: n=10 and 7; B: n=3 and 7; C: n=4 and 6; D: n=2 and 2; 704 
E,F: n=4 and 4, respectively. *P < 0.05, **P < 0.01 compared to each saline control. (G-705 
K) Mice were challenged i.n. with Alternaria alternata (Alt, 25 µg) or saline on days 1, 4, 706 
7, and 10. (G) On day 11, airway resistance in response to nebulized methacholine (12 707 
mg/mL) was measured with the FlexiVent system. (H) Eosinophils and neutrophils in 708 
BALF. (I) Western blot analysis of ORMDL, total caspase 3, and cleaved caspase 709 
3 expression in the lung. Tubulin was used as a loading control. (J) Lung ceramide 710 
species were measured by LC-ESI-MS/MS. (K) ROS was measured fluorometrically. 711 
Data are mean ± SD. G: n=4 and 3; H: n= 5 and 4; I, n= 3 and 3; J n=3 and 4; K: n= 6 712 
and 3 respectively. *P < 0.05, **P < 0.01 compared to each saline control. 713 
FIG 4. Effects of feeding α-tocopherol supplemented diet on ROS, ceramide, and 714 
apoptosis in the lung of HDM challenged mice. Mice fed chow diet without or with α-715 
tocopherol (250 mg/kg) were challenged i.n. with HDM (10 µg in 50 µL saline) every 716 
other day for a total of 8 challenges. (A) ROS in lungs was determined fluorometrically 717 
by oxidation of 2,7-dichlorofluorescein. (B) Lung ceramide species were measured by 718 
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LC-ESI-MS/MS. (C) Western blot analysis of cleaved caspase 3 in the lung. A,B: 719 
n=4,4,4, and 4 respectively. *P < 0.05, **P < 0.01, ***P < 0.01 compared to saline.  720 
FIG 5. Inhibiting ceramide production decreases ROS and apoptosis induced by 721 
HDM. (A-C) Mice were challenged daily intranasally with HDM or saline for 5 722 
consecutive days from days 1 to 5 and from days 8 to 12. Mice were injected i.p. with 723 
vehicle, myriocin (Myr; 0.3 mg/kg), or fumonisin B1 (FB1, 0.5 mg/kg) 30 min prior to the 724 
HDM challenges on days 10, 11, and 12 and lungs were examined on day 15. (A) 725 
Scheme of ceramide formation by de novo biosynthesis and degradation. Myriocin 726 
inhibits SPT and FB1 inhibits ceramide synthases (CerS). (B) Sphingolipids were 727 
extracted from BALF and ceramide and dihydroceramide species measured by LC-ESI-728 
MS/MS. (C) In situ TUNEL staining of lung sections. Size bars: 50 µm. (D) Western blot 729 
analysis of cleaved caspase 3 in the lung. (E) ROS was measured fluorometrically. Data 730 
are mean ± SD. B: n=4 for saline, 4 for HDM, 2 for saline+myriocin, 4 for 731 
HDM+myriocin; 2 for saline+FB1, 4 for HDM+FB1; D: n= 2,3 and 3 respectively; E: n=3 732 
for saline, 7 for HDM, 2 for saline+myriocin, 3 for HDM+myriocin; 2 for saline+FB1, 4 for 733 
HDM+FB1. *P < 0.05, **P < 0.01 compared to each saline control.  734 
FIG 6. Association between asthma severity and ceramide species that are 735 
increased in BALF. (A) Levels of ceramide species in BALF from healthy controls, non-736 
severe asthmatics, and severe asthmatics described in Table I were measured by LC-737 
ESI-MS/MS. * P < 0.05 compared to healthy controls. (B) Heat-map of matrix coefficient 738 
correlation of each ceramide species in the BALF and lung functions or immune cells 739 
infiltration. Visualization of the correlations between each pair of variables using 740 
product-moment coefficients. Stronger Pearson correlation coefficients (r) are 741 
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represented by black color. (C) Examples of correlations between C16 or C26:1 742 
ceramides and neutrophils, and lung functions. Goodness of fit is indicated by r2. 743 
Correlation of neutrophils with C16-ceramide (Spearman r = 0.3089 and P = 0.092) and 744 
with C26:1-ceramide (Spearman r=0.4141 and p = 0.039). Correlation of FEV1_FVC 745 
with C26:1-ceramide (Pearson r = 0.5548 and P = 0.01) and FEV1pp with C26:1-746 
ceramide (Pearson r = 0.5742, and P =0.01 ). 747 
FIG 7. Increased ceramide in HDM-challenged mice enhances neutrophil 748 
recruitment to the lungs. (A) Mice were challenged daily intranasally with HDM or 749 
saline for 5 consecutive days from days 1 to 5 and from days 8 to 12. Mice were 750 
injected i.p. with vehicle, myriocin (Myr; 0.3 mg/kg), or fumonisin B1 (FB1, 0.5 mg/kg) 30 751 
min prior to the HDM challenges on days 10, 11, and 12 and lungs were examined on 752 
day 15 as described in Figure 5. Lung sections were stained with anti-Ly6G (red) or 753 
anti-MPO antibody (green) and co-stained with DAPI to visualize nuclei (blue). Size bar: 754 
100 µm. (B,C) Primary lung epithelial cells incubated for 20 h with vehicle, D-erythro-755 
C6-ceramide (C6-Cer, 1 µM), or HDM (100 µg/mL) in absence or presence of FB1 (1 756 
µM) or myriocin (100 nM) as indicated. After extensive washing, purified labeled 757 
neutrophils were added for 4 h and adhesion assessed by fluorescence. (B) Following 758 
intranasal instillation of vehicle or C16:0 ceramide number of neutrophils in the BALF 759 
was determined by FACS. Data means ± SD. n = 8 and 10 mice/group, respectively. **P 760 
< 0.01. (C) Representative fluorescent images. (D) Data expressed as arbitrary 761 
fluorescence units are means ± SEM. n=5 for each group. Each sample represents an 762 
individual donor mouse. * p < 0.05 ** p < 0.01 compared to vehicle.  763 
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No. of subjects  
 
5 5 10 







% Male  
 









Lung function    
SARP Severity 1 3 4.4±0.5** 
(4-5) 






























Medications    
Oral steroids NO NO YES 
Inhaled 
corticosteroids 
NO YES YES 
High dose of inhaled 
corticosteroids 
NO NO YES 
BALF leukocyte 
differentials 
   









































Values represent the mean ± SD (range). BMI, body mass index; FEV1, forced 765 
expiratory volume in 1 second; FVC, forced vital capacity; BD, post-bronchodilator. 766 
** P < 0.01 compared to healthy controls. 767 
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ONLINE REPOSITORY MATERIALS  
SUPPLEMENTARY METHODS 
BALF collection and analysis  
BALF was collected by lavage of the lungs with 1 mL of PBS containing 1% BSA. 
Cellular composition of BALF was determined by fluorescence-activated cell sorting 
(FACS) as described 1, 2. Briefly, cells stained with a fixable live/dead stain, Zombie 
Aqua (Biolegend) were incubated with Fc block anti-mouse CD16/CD32 (clone 2.4G2) 
in FACS buffer (2% BSA, 2mM ETDA, PBS) on ice for 10 min to reduce non-specific 
binding. Cells were then stained with an antibody cocktail (Supplementary Table 1) in 
FACS buffer and Brilliant Violet Stain Buffer (BD) according to the manufacturer’s 
protocol. After staining and washing, cells were then fixed in 3% paraformaldehyde for 
15 min at room temperature in the dark, washed, and re-suspended in PBS for 
analyses. Cells were run on a BD-LSRFORTESSA-X20 cell analyzer equipped with 
FACSDIVA 8.0 software for acquisition (BD Biosciences). Compensations were 
performed using single stain controls and negative controls with the assistance of 
UltraComp eBeads Plus compensation beads (ThermoFisher) to optimize fluorescence 
 2
compensation settings for multicolor flow cytometric analyses. Cells were first gated 
based on forward (FSC-A) and side (SSC-A) scatter to exclude debris and then were 
gated for doublet exclusion. All cells were gated as Fixable Zombie Aqua- (Live), and 
CD45+. Unless otherwise noted, T cells were defined as CD3+MHCII-, B cells as 
B220+CD19+MHCII+, macrophages as CD11c+SiglecF+, neutrophils as CD11b+CD11c-
SiglecF-Gr1+, and eosinophils as CD11c-CD11b+SiglecF+SSChigh. Data analysis was 
performed using FlowJo version 10.4.2. 
Instillation of C16:0 ceramide 
 C16:0 ceramide conjugated to polyethylene glycol 2000 (#880180P, Avanti Polar 
Lipids) dissolved in saline or vehicle was instilled intranasally (5 mg/kg) similar to a 
previous report with minor modifications 3. After 24 h, BALF was collected and 
neutrophils (CD11b+CD11c-SiglecF-Ly6G+) quantified by FACS.  
Immunocytochemistry 
 Frozen lung sections were fixed with 4% paraformaldehyde in PBS and 
permeabilized by incubation with 0.2% Triton X-100 in PBS for 5 min at room 
temperature. Nonspecific binding sites were blocked with 3% ovalbumin/10% donkey 
serum/PBS for 1 h at 37°C. Sections were then incubated with the indicated primary 
and secondary antibodies at a concentration of 5 µg/mL or 10 µg/mL in 0.1% ovalbumin 
as described previously 4. Anti-ceramide rabbit IgG (1:200) was generated as previously 
described 5. The anti-activated caspase 3 antibody (#9661, 1:400) was obtained from 
Cell Signaling Technology (Danvers, MA). The anti-cytokeratin-18 and anti-α-smooth 
muscle actin (SMA) (1:100) antibodies were from Santa Cruz (sc-398871 and sc-
130616), anti-Ly6G was from BioLegend (clone 1A8, #127601) and anti-MPO antibody 
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from R&D Systems (#AF3667-SP). Cell nuclei were co-stained with 2 µg/mL DAPI in 
PBS for 30 min at room temperature. Paraffin lung sections were deparaffinated with 
xylene and ethanol, then microwave-irradiated and apoptotic cells were detected in situ 
with the Terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling 
(TUNEL) kit from Roche  (Millipore Sigma). Epifluorescence microscopy was performed 
with a BZ-X810 Keyence fluorescence microscope or a Nikon Ti2 Eclipse microscope 
equipped with NIS Elements software using Z-scanning with 20x and 60x (oil) objective 
at the step size recommended by the software. Images were processed using the NIS 
Elements 3D deconvolution program at settings recommended by the software 
(automated) and deconvolved images were projected onto one plane. Laboratory 
personnel, blinded to the origin of the samples collected all of the data from at least 
three independent samples. Images obtained with secondary antibody only were used 
as negative controls.  
Isolation of primary lung alveolar epithelial cells 
 Female C57BL/6J mice (8-12 weeks) were euthanized and perfused through the 
left ventricle with PBS supplemented with 0.1% heparin. The upper respiratory tract was 
exposed and the perfused lungs were dissected from the thoracic cavity and cut into 
single lobes. Tissues were placed in 15 mL conical tubes containing 5 mL of PBS with 
0.5 mg/mL Liberase (Hoffmann-La Roche, Basel, Switzerland) and 0.02 mg/mL DNAse 
1 (Sigma-Aldrich, St. Louis, Missouri, USA) and incubated for 30 min at 37 °C while 
shaking. Tissues were then dissociated mechanically and incubated further for 30 min. 
Digested tissues were passed through a 70 µm cell strainer and single cell suspensions 
centrifuged at 300 x g for 10 min at 4 °C. Cell pellets were re-suspended in 90 µl of PBS 
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containing 2 mM EDTA, 0.5% BSA, and 10 µl of CD326 (EpCAM) MicroBeads (Miltenyi 
Biotec, Bergisch Gladbach, Germany) per 107 cells. After incubation for 15 min at 4°C, 
cells were re-suspended in 500 µl PBS containing 2 mM EDTA and 0.5% BSA. Labeled 
and non-labeled cells were separated by magnetic cell sorting with LS columns and the 
QuadroMACS separation system (Miltenyi Biotec, Bergisch Gladbach, Germany) 
according to the manufacturer´s instructions. The unlabeled flow-through was discarded 
and the labeled fractions were pelleted by centrifugation and re-suspended in 2 mL of in 
epithelial cell growth medium for animals EpiCM-A (ScienCell, San Diego, USA) at 
500,000 cells/mL. Epithelial cells were cultured on poly-L-lysine-coated 6-well plates.  
Measurement of ROS production by epithelial cells 
 Primary epithelial cells were plated and cultured to confluency in black 96 well 
plates with clear bottoms (Greiner Bio-One, Kremsmünster, Austria). Cells were then 
washed with PBS, and incubated with 100 µl of a 10 µM CM-H2DCFA solution for 45 
min at 37°C, 5% CO2. The supernatants were removed and cells were washed twice 
with PBS and then stimulated for 24 h as described in figure legends. Fluorescence was 
measured with a TECAN infinite M1000 Pro fluorescence plate reader.  
Apoptosis determination with Annexin V and 7-amino-actinomycin D (7-AAD)  
 Stimulated epithelial cells were harvested, including detached cells in the 
supernatant, and after centrifugation, cells were stained with the APC Annexin V 
Apoptosis Detection Kit with 7-AAD (BioLegend, San Diego, California, USA) according 
to the manufacturer´s instructions. Apoptosis was measured by flow cytometry using a 
BD LSRFortessa X-20 equipped with BD FACSDiva software for acquisition and 
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analysis (BD Biosciences, Franklin Lakes, New Jersey, USA). Data were analyzed 
using FlowJo 10.6.2 (FlowJo, LLC, Ashland, Oregon, USA).  
Neutrophil isolation and neutrophil attachment assay 
 Primary neutrophils were isolated from lungs from female C57BL/6J mice by 
magnetic labeling of Ly-6G-positive cells. Briefly, mouse lungs were harvested and 
digested as described above. Single cell suspensions were centrifuged at 300 x g, 10 
min, 4 °C, and the cell pellets re-suspended in 90 µl of PBS containing 2 mM EDTA, 
0.5% BSA, and 10 µl of anti-Ly-6G MicroBeads (Miltenyi Biotec, Bergisch Gladbach, 
Germany) per 107 cells. After incubation for 15 min at 4°C, the cells were re-suspended 
in 500 µl PBS containing 2 mM EDTA and 0.5% BSA, and separated by magnetic cell 
sorting with LS columns and the QuadroMACS separation system. The positive labeled 
cell fraction was centrifuged and re-suspended in 10 mL of 5 µM CellTrace CFSE dye 
(Invitrogen Molecular Probes, Eugene, Oregon, USA) in PBS. Cells were incubated for 
15 min at 37°C and 40 mL of epithelial cell growth medium was added. After 5 min, cells 
were centrifuged for 5 min at 300 x g, 4 °C, and resuspended in epithelial cell growth 
medium at a cell density of 500,000 cells/mL. Primary epithelial cells were stimulated for 
20 h as described in figure legends, and the supernatant was removed and replaced by 
200 µl of the labeled neutrophil cell suspension. After 4 h, non-attached cells were 
carefully removed by three washes with PBS. During the last wash, the attached 
neutrophils were examined with the ZOE Fluorescent Cell Imager (Bio-Rad 
Laboratories, Hercules, California, USA). Cells were then lysed in 150 µl lysis buffer (50 
mM NaCl solution with 10% SDS) for 5 min while shaking. 100 µL of the mixture was 
transferred to a black 96-well plate with clear bottom (Greiner Bio-One, Kremsmünster, 
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Austria). Fluorescence was measured at excitation and emission wavelengths of 492 
and 517 nm with a TECAN Infinite M1000 fluorescence plate reader (Männedorf, 
Switzerland). 
Western blot analysis 
 Snap frozen lung tissues were homogenized in buffer containing 50 mM Tris (pH 
7.4), 150 mM NaCl, 1% NP-40, 2 mM sodium orthovanadate, 4 mM sodium 
pyrophosphate, 100 mM NaF, and 1:500 protease inhibitor mixture (Sigma). Equal 
amounts of protein were loaded and separated on 15% SDS-PAGE gels and transferred 
onto 0.45 µm nitrocellulose membranes using the PierceG2 Fast Blotter system 
(Thermo Scientific). 5% nonfat dry milk (BioRad) in TBS-T was used for blocking, and 
membranes were incubated with the following primary antibodies: anti-ORMDL3 
(1:1000; CAT#ABN417, Millipore); anti-caspase 3 (1:1000; CAT#9662S, Cell Signaling); 
anti-cleaved capase 3 (1:1000; CAT#9664S, Cell Signaling); and anti-tubulin (1:20,000; 
CAT#2146S, Cell Signaling). Peroxidase-conjugated goat anti-rabbit secondary 
antibody (1:5000; Jackson ImmunoResearch) and chemiluminescent substrate (Pierce) 
were used to visualize protein bands.  
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SUPPLEMENTARY FIGURE LEGENDS 
Figure E1. HDM induces lung apoptosis. Mice were sensitized and challenged 
intranasally with HDM or saline and lung sections were stained with anti-cleaved 
caspase 3 antibodies. Bar: 100 µm. 
Figure E2. Lack of autofluorescence of lung sections shown in Figure 2 stained with 
DAPI (blue). 
Figure E3. Increased lung ceramide by HDM partially co-localized with airway 
smooth muscle cells. Mice were challenged i.n. with HDM or saline and lungs 
examined on day 15. Lung sections were stained with anti-ceramide antibody (red) and 
anti-SMA (green). All sections were co-stained with DAPI to visualize nuclei (blue). Co-
localization is shown in the overlay panels. Bar: 50 µm. 
Figure E4. Increased ceramide staining in HDM-challenged mice co-localizes with 
cleaved caspase 3 and cytokeratin 18, marker for epithelial cells. (A) Mice were 
challenged i.n. with HDM or saline and lungs as indicated and examined on day 15 as 
described in Fig 1. Lung sections were stained with anti-ceramide antibody, anti-cleaved 
caspase 3 antibody, anti-cytokeratin 18, and co-stained with DAPI. Co-localization is 
shown in the overlay panel. Size bar: 10 µm.  
Figure E5. HDM challenge increases BALF dihydro-ceramides and ceramides. 
Mice were challenged daily i.n. with HDM or saline for 5 consecutive days from days 1 
to 5 and from days 8 to 12. Mice were injected i.p. with vehicle, myriocin (Myr; 0.3 
mg/kg), or fumonisin B1 (FB1, 0.5 mg/kg) 30 min prior to the HDM challenges on days 
10, 11, and 12 and sphingolipids were extracted from BALF on day 15 and total levels 
of dihydroceramide (DH-Cer), monohexosyldihydroceramide (DH-HexCer), 
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dihydrosphingomyelin (DH-SM), ceramide (Cer), monohexosylceramide (HexCer), and 
sphingomyelin (SM) were measured by LC-ESI-MS/MS.  n=4 and 7 respectively. Data 
are means ± SEM. *** p < 0.001 compared to saline. 
Figure E6. HDM induces apoptosis and ROS in lung epithelial cells in a ceramide-
dependent manner. (A) Representative flow cytometry analysis of primary lung 
epithelial cells treated with the vehicle or HDM (100 µg/mL) for 24 h followed by Annexin 
V and 7-AAD staining. (B,C) Primary lung epithelial cells were treated with vehicle, C6-
ceramide (1 µM), HDM (100 µg/mL) in absence or presence of FB1 (1 µM), myriocin 
(100 nM) as indicated. (B) Cells were stained with Annexin V and 7-AAD and percent 
viable and apoptotic cells (Annexin V+) determined by flow cytometry. (C) Increased 
ROS in cells was measured by oxidation of 2,7-dichlorofluorescein to fluorescent DCF. 
Data are means ± SD. B n=3 for each group; C: n=5 for each group. Each sample 




Supplementary Table 1: Antibodies used 
 
Target Conjugate Company Clone 
Product 
Number 
Live/Dead Zombie Aqua Biolegend  423102 
CD45 FITC Biolegend 30-F11 103108 
CD45 APC-Fire750 Biolegend 30-F11 104154 
CD3e BV711 Biolegend 145-2C11 100349 
CD3e BUV737 BD 145-2C11 564618 
B220 PE Biolegend RA3-6B2 103208 
B220 BUV737 BD RA3-6B2 564449 
CD11b PE/Cy7 Biolegend M1/70 101216 
CD11b APC-Fire750 Biolegend M1/70 101262 
MHCII BV421 Biolegend M5/114.15.2 107632 
MHCII BV650 Biolegend M5/114.15.2 107641 
Gr1 PE Biolegend RB6-8C5 108408 
Ly6G FITC Biolegend 1A8 127606 
SiglecF AF647 BD E50 2440 562680 
CD11c BV605 Biolegend N418 117334 
CD11c BV711 Biolegend N418 117349 
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Figure  E3 
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Allergen-induced ceramide elevation leads to cell death, oxidative 
stress, and neutrophil infiltration in allergic asthma  
Abbreviations
i.n. : intranasal injection; SA: severe asthma; HD: healthy donors; BAL: broncholoalveolar lavage;  LC-
ESI-MS/MS: liquid chromatography electrospray ionization-tandem mass spectrometry; DC: dendritic 
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